HCPLive Network

Internal Medicine World Report

Cardiology
Discrepancy Among Device Therapy Requirement Evaluation Methods
By Rachel Lutz
Device therapy eligibility requirements are underestimated using 2D echocardiography compared to cardiac magnetic resonance imaging, according to a study from the Netherlands Heart Journal.
Pulmonology
Brief Report, Big Message: Profile of Pneumonia Pathogens Changed
By Jeannette Wick
A letter published online in the Journal of the American Medical Association presents the first microbiologic pathogens trend analysis in hospitalized patients in the United States.
Older Folks and Influenza: High Dose Vaccine 24% More Effective
By Jeannette Wick
Scientists from Sanofi Pasteur’s Swiftwater, PA facility have published results of a study indicating that a high-dose, trivalent, inactivated influenza vaccine (IIV3-HD or high dose Fluzone®) improves antibody responses to influenza among adults 65 years of age or older.
Rheumatology
Increased Development in Carpal Tunnel Syndrome
By Adam Hochron
As people spend more time sitting and working in front of computer screens, studies have shown the risk of developing carpal tunnel syndrome (CTS) has grown. A team of researchers recently worked to take a deeper look at specific factors and their roles in the development in the condition.
Psychiatry
Addressing Behavior Concerns in Adolescents with Omega-3 Supplements
By Rachel Lutz
Omega-3 supplementation can help reduce behavioral issues in adolescents who may be particularly prone to oxytocin receptor gene methylation.
Withdrawal Symptoms Cease over 12 Months When Cannabis Users Acknowledge Use
By Rachel Lutz
Cannabis users who acknowledge their problem and report withdrawal symptoms are likely to increase abstinence over a 12-month period, according to research published in the Journal of Addiction Medicine.
Mental Health Drugs: High Risk for Adverse Events
By Jeannette Wick
Prescription medications for mental health diagnoses (e.g. antidepressants, antipsychotics, and mood stabilizers) consume approximately 25% of commercial health insurers’ pharmacy budgets and almost 35% of public payers’ pharmacy spending. In 2011, an estimated 26.8 million US adults—more than 11%—took prescription medications for mental illness.